Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

類似資料

• Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis
  著者:: Richter, A, 等
  出版事項: (2016)
• Evaluation of the RABBIT Risk Score for serious infections
  著者:: Zink, A, 等
  出版事項: (2014)
• Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
  著者:: Listing, Joachim, 等
  出版事項: (2015)
• Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort
  著者:: Meissner, Y, 等
  出版事項: (2017)
• Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT
  著者:: Gerhold, Kerstin, 等
  出版事項: (2015)